Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:ARCK

Arbor Rapha Capital Bioholdings Corp. I (ARCK) Stock Price, News & Analysis

Arbor Rapha Capital Bioholdings Corp. I logo

About Arbor Rapha Capital Bioholdings Corp. I Stock (NASDAQ:ARCK)

Key Stats

Today's Range
$11.90
$11.90
50-Day Range
$10.42
$15.41
52-Week Range
$9.93
$15.59
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Arbor Rapha Capital Bioholdings Corp. I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar Business Combination with one or more businesses. It intends to identify acquisition opportunities in the biopharmaceutical sector. The company was incorporated in 2021 and is based in Uniondale, New York.

Receive ARCK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arbor Rapha Capital Bioholdings Corp. I and its competitors with MarketBeat's FREE daily newsletter.

ARCK Stock News Headlines

DRGV Dragon Capital Group, Corp.
ECN Capital Corp. (ECNCF)
I've got news for you…
Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week
SuRo Capital Corp.
Ready Capital Corp.
Oxford Lane Capital Corp. (OXLC)
Deal Pro Capital Corporation (DPCC-P.V)
Quad 7 Capital
See More Headlines

ARCK Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Arbor Rapha Capital Bioholdings Corp. I investors own include Criteo (CRTO), AzurRx BioPharma (AZRX), Alnylam Pharmaceuticals (ALNY), Argos Therapeutics (ARGSQ), Editas Medicine (EDIT), Abrdn Asia-Pacific Income Fund (FAX) and Weidai (WEI).

Company Calendar

Today
11/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:ARCK
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:ARCK) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners